-
PET signal can be misdiagnosed after lung biopsy or wedge removal
Time of Update: 2020-07-06
a study the Mayo Hospital in the United States, a lung tumor patients who ingestave radioactive tracer in positor-fired tomography (PET) after an invasive lung test (pontoun biopsy) may increase
-
Analysis of the novel coronavirus pneumonia in the severe situation of different types of vaccine research progress
Time of Update: 2020-06-19
Background at present, the new crown epidemic situation presents different development trends at home and abroad On the one hand, the decisive control measures in China after the outbreak of
-
Immunotherapy helps HIV-infected people with cancer treatment
Time of Update: 2020-06-09
Fred Hutch immunotherapy researcher Dr Mac Cheever is director of the Cancer Immunotherapy Pilot Organization and senior author of the JAMA Oncology paper The study was conducted at seven different ca
-
FDA approves "first-in-class" innovative therapy to treat excessive drowsiness in the day
Time of Update: 2020-06-08
Seizure apsydal sleep ingestis is a rare neurological disease in which patients experience drowsiness symptoms due to their inability to regulate the cycle of sleep and wakefulness The two main sympto
-
Insufficient rehydration detection by sweat-testing drink-driving
Time of Update: 2020-06-06
Jan Haramek, an associate professor in the Department of Chemistry at the University of Albany in the United States, claims to have invented a weapon that uses sweat to accurately and quickly detect a
-
The Latest: Drug Patent Link System Is Coming
Time of Update: 2020-06-01
"Opinion" has two bright spots: highlights one: opinion requirements, improve the new industry protection system in new areas Explore the establishment of drug patent link system, drug patent term co
-
Clinical trial streating patients with severe COVID-19 with The C5 inhibitor Ululizumab-cwvz: upcoming
Time of Update: 2020-05-29
Alexion Pharmaceuticals said recently that it plans to launch a Phase III study of ravulizumab-cwvz for patients with COVID-19 acute respiratory distress syndrome Ultomiris (ravulizumab-cwvz), a C5
-
Xinda biology and adimab cooperate to develop therapeutic antibody
Time of Update: 2020-04-03
On August 20, Cinda biopharmaceutical (Suzhou) Co., Ltd announced that it has signed a development and commercialization plan for therapeutic antibody with adimab company of the United States The main
-
FDA issued a letter, this big variety may face de-listing
Time of Update: 2020-04-03
On April 1, the FDA issued a letter requiring manufacturers to immediately withdraw all prescriptions and OTC retintin drugs from the market, the reason for this action is that the FDA has determined
-
Hanyu Pharmaceutical Co., Ltd. has accepted the raw materials and preparations of ticlopeptide and nesiritide
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on March 27, Hanyu Pharmaceutical Co., Ltd centrally applied for the acceptance of the three kinds of clinical drugs, i.e the
-
Zhongsheng Pharmaceutical Co., Ltd.: RuiChuang liver disease innovative medicine, a subsidiary, obtained the US patent certificate
Time of Update: 2020-01-19
On January 17, Zhongsheng pharmaceutical released a notice that Zhongsheng RuiChuang, the holding subsidiary of the company, received a patent certificate issued by the US patent and Trademark Office,
-
Challenge oral anticoagulants! First batch of eliquis imitated drugs approved by FDA
Time of Update: 2019-12-26
Recently, FDA approved micro Labs Limited and mylan's apixaban generic, indications are: (1) for patients with nonvalvular atrial fibrillation, to reduce the risk of stroke and systemic embolism; (2)
-
Animal studies show that social isolation during adolescence can lead to brain development disorders
Time of Update: 2019-09-19
A new study in the United States found that if female mice were isolated during puberty, their prefrontal cortex in the brain would develop atypical, and in adulthood, they would have excessive depend
-
Five categories of products "no chance" 2019 medical insurance catalog? Multinational pharmaceutical companies "seize" China's 100 billion market and face four challenges
Time of Update: 2019-04-22
Four categories of products are expected to be transferred in, and five categories of products will be transferred out "soon" On April 17, the State Health Insurance Bureau officially released the wor
-
Good news! Humanwell's anxiety medicine, with an annual sales volume of nearly US $100 million, has been approved in the United States
Time of Update: 2019-04-19
On April 17, humanwell pharmaceutical announced that the buspirone hydrochloride tablets of its wholly-owned subsidiary epic Pharma, LLC (hereinafter referred to as epic Pharma) have passed anda (brie
